6 documents

Read All
22:54 , Sep 14, 2017 |  BC Innovations  |  Targets & Mechanisms

Platelets YAP at cancer

While elevated platelet levels often signify an underlying malignancy, the molecular mechanisms linking the two are not well understood. Now, a team from MD Anderson has shown a well-known, but barely exploited signaling pathway mediates...
Read More
18:16 , Feb 2, 2017 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Breast cancer Cell culture and mouse studies suggest inhibiting ROR1 or the long non-coding RNA (lncRNA) MAYA could help treat bone-metastatic breast cancer. In a bone-metastatic human breast cancer line, ROR1 knockout or MAYA...
Read More
07:00 , Oct 31, 2013 |  BC Innovations  |  Distillery Techniques

Technology: Markers

Approach Summary Licensing status Publication and contact information Markers Gene expression signature to predict outcome in patients with idiopathic pulmonary fibrosis (IPF) Studies in patient samples identified a gene...
Read More
07:00 , May 19, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Inflammatory bowel disease (IBD) BH3 interacting domain death agonist (BID); caspase recruitment...
Read More
07:00 , Jul 23, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Various

Indication Target/marker/pathway Summary Licensing status Publication and contact information Various Autoimmune; inflammatory disease Baculoviral...
Read More
08:00 , Jan 4, 1999 |  BC Week In Review  |  Company News

Xenova other research news

The University of Georgia (Athens, Ga.) received a five-year, $500,000 per year grant from the NIH's International Cooperative Biodiversity Groups (ICBG) Program to fund a medical ethnobiology and biodiversity inventory of the Highland Region of...
Read More